Lupien P J, Moorjani S, Awad J
Lancet. 1976 Jun 12;1(7972):1261-5. doi: 10.1016/s0140-6736(76)91736-0.
Reduction of plasma-cholesterol by the removal of low-density lipoproteins (L.D.L.) in an extracorporeal system is described as a possible approach in the treatment of familial hypercholesterolaemia. L.D.L. were removed from the blood by their interaction with heparin linked to agarose beads in the presence of calcium ions. Plasma-L.D.L. was markedly decreased in two patients with heterozygous familial hypercholesterolaemia. The technique is specific for the removal of L.D.L., as the concentration of high-density lipoproteins was not affected. The treatment was well tolerated by all three subjects (i.e., two hypercholesterolaemic patients and a normal volunteer), and there were no undesirable effects. Several haematological parameters, clinical-chemistry tests, including serum enzymes, and immunoelectrophoresis of plasma proteins were all unaffected by the treatment.
在体外系统中通过去除低密度脂蛋白(L.D.L.)来降低血浆胆固醇被描述为治疗家族性高胆固醇血症的一种可能方法。在钙离子存在的情况下,L.D.L. 通过与连接到琼脂糖珠上的肝素相互作用从血液中被去除。两名杂合子家族性高胆固醇血症患者的血浆L.D.L. 显著降低。该技术对去除L.D.L. 具有特异性,因为高密度脂蛋白的浓度不受影响。所有三名受试者(即两名高胆固醇血症患者和一名正常志愿者)对该治疗耐受性良好,且没有不良影响。几项血液学参数、包括血清酶在内的临床化学测试以及血浆蛋白的免疫电泳均不受该治疗影响。